-
公开(公告)号：US20170258855A1
公开(公告)日：2017-09-14
申请号：US15606208
申请日：2017-05-26
申请人： REBIOTIX, INC.
CPC分类号： A61K35/74 , A01N1/0221 , A01N1/0263 , A01N1/0273 , A61K9/0031 , A61K9/0053 , A61K35/38 , A61K47/10 , A61K2201/06 , B65B2220/16 , C12N1/20 , C12Q1/04
摘要： Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
-
公开(公告)号：US20160058804A1
公开(公告)日：2016-03-03
申请号：US14939669
申请日：2015-11-12
申请人： Rebiotix, Inc.
IPC分类号： A61K35/741 , A61K35/744 , A61K35/747
CPC分类号： A61K35/74 , A01N1/021 , A01N1/0284 , A61K9/0031 , A61K9/0053 , A61K35/38 , A61K35/741 , A61K35/742 , A61K35/744 , A61K35/747 , A61K47/10 , A61K2201/06 , A61P1/00 , B65B7/02 , B65B25/00 , C12N1/20 , C12Q1/04 , Y02A50/401 , Y02A50/463
摘要： Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
-
公开(公告)号：US20140363399A1
公开(公告)日：2014-12-11
申请号：US14319852
申请日：2014-06-30
申请人： Rebiotix, Inc.
CPC分类号： A61K35/74 , A01N1/021 , A01N1/0284 , A61K9/0031 , A61K9/0053 , A61K35/38 , A61K35/741 , A61K35/742 , A61K35/744 , A61K35/747 , A61K47/10 , A61K2201/06 , A61P1/00 , B65B7/02 , B65B25/00 , C12N1/20 , C12Q1/04 , Y02A50/401 , Y02A50/463
摘要： Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
-
公开(公告)号：US20170281693A1
公开(公告)日：2017-10-05
申请号：US15630234
申请日：2017-06-22
申请人： REBIOTIX, INC.
IPC分类号： A61K35/74 , C12Q1/04 , A61K35/741 , A61K35/742 , A61K9/00 , A61K35/744 , A61K35/747 , A01N1/02 , A61K47/10 , A61K35/38
CPC分类号： A61K35/74 , A01N1/021 , A01N1/0284 , A61K9/0031 , A61K9/0053 , A61K35/38 , A61K35/741 , A61K35/742 , A61K35/744 , A61K35/747 , A61K47/10 , A61K2201/06 , A61P1/00 , B65B7/02 , B65B25/00 , C12N1/20 , C12Q1/04 , Y02A50/401 , Y02A50/463
摘要： Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
-
公开(公告)号：US20160354414A1
公开(公告)日：2016-12-08
申请号：US15239287
申请日：2016-08-17
申请人： REBIOTIX, INC.
IPC分类号： A61K35/74 , A01N1/02 , A61K35/744 , A61K35/742 , A61K47/10 , A61K9/00
CPC分类号： A61K35/74 , A01N1/021 , A01N1/0284 , A61K9/0031 , A61K9/0053 , A61K35/38 , A61K35/741 , A61K35/742 , A61K35/744 , A61K35/747 , A61K47/10 , A61K2201/06 , A61P1/00 , B65B7/02 , B65B25/00 , C12N1/20 , C12Q1/04 , Y02A50/401 , Y02A50/463
摘要： Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
-
公开(公告)号：US09433651B2
公开(公告)日：2016-09-06
申请号：US14319852
申请日：2014-06-30
申请人： Rebiotix, Inc.
IPC分类号： A01N63/00 , A61K35/741 , A61K35/74 , A61K47/10 , C12Q1/04 , A61K35/38 , A61K35/742 , A61K35/744 , A61K35/747
CPC分类号： A61K35/74 , A01N1/021 , A01N1/0284 , A61K9/0031 , A61K9/0053 , A61K35/38 , A61K35/741 , A61K35/742 , A61K35/744 , A61K35/747 , A61K47/10 , A61K2201/06 , A61P1/00 , B65B7/02 , B65B25/00 , C12N1/20 , C12Q1/04 , Y02A50/401 , Y02A50/463
摘要： Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
-
公开(公告)号：US20140349978A1
公开(公告)日：2014-11-27
申请号：US14454886
申请日：2014-08-08
发明人： Chris Gerlach , Mike Davies
CPC分类号： A61K47/18 , A61K8/042 , A61K8/368 , A61K8/41 , A61K8/42 , A61K9/0014 , A61K9/06 , A61K31/60 , A61K2201/06 , A61K2800/52 , A61Q5/006 , A61Q5/02 , A61Q19/00
摘要： A concentrated salicylic acid gel comprising salicylic acid and a stabilizer compound, wherein the salicylic acid comprises at least 30 wt % of the total weight of the gel.
摘要翻译： 包含水杨酸和稳定剂化合物的浓缩水杨酸凝胶，其中水杨酸占凝胶总重量的至少30重量％。
-
公开(公告)号：US20170354734A1
公开(公告)日：2017-12-14
申请号：US15688560
申请日：2017-08-28
发明人： Chris Gerlach , Michael Davies
IPC分类号： A61K47/18 , A61Q5/00 , A61K9/00 , A61Q19/00 , A61K31/60 , A61K8/42 , A61K8/04 , A61K9/06 , A61K8/41 , A61K8/368 , A61Q5/02
CPC分类号： A61K47/18 , A61K8/042 , A61K8/368 , A61K8/41 , A61K8/42 , A61K9/0014 , A61K9/06 , A61K31/60 , A61K2201/06 , A61K2800/52 , A61Q5/006 , A61Q5/02 , A61Q19/00
摘要： A concentrated salicylic acid gel comprising salicylic acid and a stabilizer compound, wherein the salicylic acid comprises at least 30 wt % of the total weight of the gel.
-
公开(公告)号：US09675648B2
公开(公告)日：2017-06-13
申请号：US14295686
申请日：2014-06-04
申请人： Rebiotix, Inc.
IPC分类号： A01N63/00 , C12N1/00 , C12N1/20 , A61K35/74 , A61K47/10 , C12Q1/04 , A61K35/741 , A61K35/38 , A61K35/742 , A61K35/744 , A61K35/747 , A01N1/02 , A61K9/00
CPC分类号： A61K35/74 , A01N1/021 , A01N1/0284 , A61K9/0031 , A61K9/0053 , A61K35/38 , A61K35/741 , A61K35/742 , A61K35/744 , A61K35/747 , A61K47/10 , A61K2201/06 , A61P1/00 , B65B7/02 , B65B25/00 , C12N1/20 , C12Q1/04 , Y02A50/401 , Y02A50/463
摘要： Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
-
公开(公告)号：US20150216917A1
公开(公告)日：2015-08-06
申请号：US14689464
申请日：2015-04-17
申请人： REBIOTIX, INC.
IPC分类号： A61K35/744 , A61K35/742 , A61K35/74
CPC分类号： A61K35/74 , A01N1/021 , A01N1/0284 , A61K9/0031 , A61K9/0053 , A61K35/38 , A61K35/741 , A61K35/742 , A61K35/744 , A61K35/747 , A61K47/10 , A61K2201/06 , A61P1/00 , B65B7/02 , B65B25/00 , C12N1/20 , C12Q1/04 , Y02A50/401 , Y02A50/463
摘要： Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
-
-
-
-
-
-
-
-
-
搜索结果
17 条记录 (耗时 0.025 秒)
